Skip to content
markets · 04Insurance & Benefitsall markets →

A population read without another questionnaire.

Insurance & Benefitssona-2

You understand your population through claims, which describe what already happened, and surveys, which most members ignore. Your engagement rates on health risk assessments are what they are.

What's missing

The interactions you already have with members are voice interactions. Call centre conversations, benefits enquiries, care navigation calls. Every one of them is a health-relevant sample your organisation records and analyses only for quality assurance.

What arrives

Wellness-framed signal across mood, energy, stress, fatigue, hydration and cardiometabolic markers. Non-clinical framing throughout, appropriate for a population that has not consented to clinical screening.

Reported at cohort level for programme design, or longitudinally where a member has opted in to ongoing monitoring.

Where it fits

Existing member call infrastructure or your benefits application. No new touchpoint, no additional member burden, no separate consent flow for the interaction itself.

What it doesn't do

This is the market where the limits matter most, so they are absolute.

Nothing produced here may inform coverage decisions, underwriting, claims adjudication, or any determination affecting an individual member's benefits. Not with consent, not in aggregate, not as one input among several. Deployments are structured so that this is not possible rather than merely prohibited.

Member consent is required and is your responsibility to obtain. Genetic and biometric privacy law applies and varies by state.

what happens next

See it against your own workflow.

We'll walk through what applies in insurance & benefits, what doesn't, and where the limits sit, before any commitment.

request a walkthrough

Amplifier's voice analysis is not FDA approved and is not a diagnostic device. Narrative interpretations are provided to qualified care or research staff only, never as automated alerts and never directly to the person analyzed.

next: Research & Life Sciences